Form 4 · Filed May 5, 2026, 11:03 PM UTC
BBOT/BridgeBio Oncology Therapeutics, Inc.
Beltran Pedro — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | F | other | 1,047 | $9 | $9,454 | 45,623 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-207035